Pipeline Watch: Phase III Starts In Myelofibrosis, Birch Allergy, Non-Hodgkin's Lymphoma

Multiple COVID-19 Approvals

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.